Long-Term Survival Benefit of Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria: Data from the International PNH Registry

被引：1

作者：

Terriou, Louis ^{[1
]}

Patriquin, Christopher J. ^{[2
]}

Griffin, Morag ^{[3
]}

Lee, Jong Wook ^{[4
]}

Gustovic, Philippe ^{[5
]}

Patel, Ami S. ^{[6
]}

Szer, Jeff ^{[7
,8
]}

机构：

[1] CHU Lille, Serv Med Interne & Immunol Clin, Lille, France

[2] Univ Toronto, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada

[3] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England

[4] Catholica Univ Korea, Seoul St Marys Hosp, Catholica Hematol Hosp, Dept Hematol, Seoul, South Korea

[5] Alexion, AstraZeneca Rare Dis, Zurich, Switzerland

[6] Alexion, AstraZeneca Rare Dis, Boston, MA USA

[7] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Australia

[8] Royal Melbourne Hosp, Melbourne, Australia

来源：

关键词：

D O I：

10.1182/blood-2021-153560

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2188

引用

页数：5